XML 15 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Income and Comprehensive Income (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Oct. 01, 2017
Sep. 25, 2016
Oct. 01, 2017
Sep. 25, 2016
Revenues $ 21,047 $ 19,631 $ 63,022 $ 60,835
Cost of Products Sold 14,792 13,634 43,656 42,533
Gross Profit 6,255 5,997 19,366 18,302
Operating Expenses:        
Research and Development 1,355 1,357 3,678 4,438
Selling, General and Administrative 3,637 3,502 11,262 11,745
Total Operating Expenses 4,992 4,859 14,940 16,183
Operating Income 1,263 1,138 4,426 2,119
Other (Expense) Income:        
Interest and Financing Expense (38) (50) (147) (213)
Miscellaneous (20) 20 (53) 46
Income Before Income Taxes 1,205 1,108 4,226 1,952
Income Tax Provision 104 92 370 213
Net Income 1,101 1,016 3,856 1,739
Non-Controlling Interest (3) 3 (8) 25
Net Income Attributable to Ultralife Corporation 1,098 1,019 3,848 1,764
Other Comprehensive Income (Loss):        
Foreign Currency Translation Adjustments 440 (613) 1,193 (1,314)
Comprehensive Income Attributable to Ultralife Corporation $ 1,538 $ 406 $ 5,041 $ 450
Net Income Per Share Attributable to Ultralife Common Shareholders – Basic (in dollars per share) $ 0.07 $ 0.07 $ 0.25 $ 0.12
Net Income Per Share Attributable to Ultralife Common Shareholders – Diluted (in dollars per share) $ 0.07 $ 0.07 $ 0.24 $ 0.11
Weighted Average Shares Outstanding – Basic (in shares) 15,564 15,207 15,495 15,262
Potential Common Shares (in shares) 407 91 323 184
Weighted Average Shares Outstanding - Diluted (in shares) 15,971 15,298 15,818 15,446